Dr. Trevor Martin is the co-founder and CEO of Mammoth Biosciences, a biotechnology company based in the San Francisco Bay Area that is harnessing the diversity of nature to power the next generation of CRISPR products to detect and cure disease. Through its discovery of novel CRISPR systems, the company is enabling the full potential of its platform to read and write the code of life. Trevor earned his BA from Princeton University and his Ph.D. in Biology from Stanford. His scientific work has been featured in outlets including FiveThirtyEight and The Atlantic. He is the featured healthcare honoree on the Forbes 30 Under 30 list, is on Fortune’s 40 Under 40 list, and is an EY Entrepreneur of the Year 2021.